IL7 is a nonredundant cytokine, essential for T cell survival and development in humans. We genotyped nine tagging single nucleotide polymorphisms (SNP), representing all parts of the IL7 gene, in 1210 Swedish multiple sclerosis (MS) patients and 1234 healthy controls. None of the SNPs showed a significantly different distribution in MS, and haplotype analysis also failed to reveal differences between patients and controls. We conclude that the IL7 gene is very unlikely to influence the genetic susceptibility to MS in this population.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), affecting more than one in a thousand in most western countries. It is considered to be a complex disease where both genetic and environmental factors contribute to the pathogenesis (Willer et al., 2003) . IL7 is a nonredundant, essential cytokine in the human T cell development and survival, and it has also been shown to be of importance in survival and proliferation of mature T cells in the periphery (Jiang et al., 2005) . The mechanisms of IL7 production are not fully understood, but IL7 has been reported to be expressed in stromal tissues, epithelial cells in the thymus and in the bone marrow (Wiles et al., 1992) . It binds to the interleukin 7 receptor (IL7R), a complex composed of the common cytokine receptor gamma chain, γ c and the IL7R-α chain (Ziegler et al., 1995) . The IL7 gene is located on chromosome 8q12-q13 spanning 72 kb and harbour six exons.
Material and methods

Patients and controls
A Swedish case/control material consisting of DNA from 1210 MS patients (73% females and 27% males,) fulfilling either the criteria of Poser for definite MS or the criteria of McDonald for MS was analyzed (Poser et al., 1983; McDonald et al., 2001 ). The disease course was primary progressive in 6.8% of the MS patients. DNA from 1234 blood donors (63% females and 37% males, with a mean age at sampling of 45.6 years) was collected as control samples, with matched ethnicity to the patient group. Informed consent was obtained from all patients and controls, and the ethical committee approved the study.
SNP selection and genotyping
All SNPs selected for genotyping were accessed from the public dbSNP (http://www.ncbi.nih.gov) and the HapMap (http://www.hapmap.org/). Nine SNPs were selected for genotyping in order to tag the linkage disequilibrium (LD) blocks harbouring the IL7 gene, aiming to acquire genotype information for a larger number of SNPs within and surrounding the IL7. 
